Hostname: page-component-cb9f654ff-lqqdg Total loading time: 0 Render date: 2025-08-29T20:40:17.155Z Has data issue: false hasContentIssue false

Efficacy of lisafentamine treatment in adult patients with comorbid ASD and ADHD: case series

Published online by Cambridge University Press:  26 August 2025

A. Izquierdo De La Puente*
Affiliation:
Psiquiatria
S. T. Romero
Affiliation:
Psicología, Hospital Universitario Puerta de HIerro de Majadahonda
P. Del Sol Calderon
Affiliation:
Psiquiatria
R. Fernandez Fernandez
Affiliation:
Psiquiatria, Hospital Universitario Infanta Cristina, Madrid, Spain
E. Antolin Murillo
Affiliation:
Psicología, Hospital Universitario Puerta de HIerro de Majadahonda
P. Martinez Marin
Affiliation:
Psicología, Hospital Universitario Puerta de HIerro de Majadahonda
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

A case series of patients diagnosed with comorbid ASD and ADHD in adulthood is presented.

Objectives

To make a comparison between the situation and social difficulties before and after specific ADHD treatment, in order to reinforce that it is not only a treatment for academic functioning, but also helps social interaction and therefore general functioning.

Methods

Four clinical cases are presented, three females and one male, with a mean age of 45 years. All of them were diagnosed with ASD and comorbid ADHD, with a predominance of impulsive component, in 2023.

All of them, prior to the diagnosis of ASD, were diagnosed with GAD, social phobia or even avoidant personality disorder. For these diagnoses, from a very early age, they received different SSRIs and benzodiazepines with little response.

Results

In the consultation, after taking a complete clinical history, and fundamentally a biographical history, the examination was complemented with ADOS and CPT.

Due to the results obtained in CPT, it was decided to start treatment with lisafentamine between 50 and 70mg DMD.

CPT was performed again, obtaining better results in all cases, with a decrease in impulsivity and attention, mainly. At a subjective level, patients reported a substantial improvement, especially at a social level, which favoured their functioning in basic activities of daily living.

Conclusions

In adults, a correct diagnosis is important given that many of them present symptoms compatible with one or more neurodevelopmental disorders not diagnosed in childhood. Likewise, treatment in accordance with these disorders improves functionality and avoids polypharmacy and side effects of unnecessary treatments.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.